Dear ASPS community, Last weekend August 3-4, 2024 Team ASPS rode for the 21st time...
The Rare Cancer Research Foundation (RCRF) is a 501(c)3 dedicated to curing rare cancers through...
New Therapeutic Targets in Alveolar Soft Part Sarcoma were revealed in a new study conducted...
The first weekend of August 2023 is marking 20 years of iCureASPS efforts to find...
Join us to watch a live webinar on ASPS on Wednesday, April 26, 9:00-11:00 AM...
On December 9, 2022, the Food and Drug Administration (FDA) approved atezolizumab (Tecentriq, Genentech, Inc.)...